Udupi: Collision of motorbikes claims life of 16-year-old PU student

Mangaluru, May 13: Dakshina Kannada today recorded its fourth death due to novel coronavirus.

The victim, identified by number P-536, is a 58-year-old woman from Boloor area of Manglauru. She was tested covid-19 positive on April 30. 

A patient with TB meningitis, the woman had been treated and discharged from Mangaluru’s First Neuro Hospital, which has emerged as covid-19 hub of coastal Karnataka.

In hospital she had reportedly come in contact with patient No 501 who worked as a sweeper in the same hospital. 

With this death, the number of active covid-19 cases reduced to 16 in Dakshina Kannada. The district has so far reported 34 covid-19 cases including four deaths. 14 have been discharged.

Mangaluru, July 23: Lavanya Ballal, national co-coordinator for social media department of Indian National Congress, has accused the Bharatiya Janata Party of destroying the nation by misleading the youth.

In an interview with a regional Kannada news paper, the Dakshina Kannada based activist, lamented that instead of using social media for the welfare of the nation, BJP leaders used it to spread lies for their political gains. 

On one hand BJP fooled people through false promises and colourful dialogues, while on the other hand it misled crores of youth by spreading fake news, twisted facts and false information, she said.

Ms Ballal went on to accuse BJP of following the footsteps of the British. “BJP is following all the methods employed by the British invaders to divide the people of India and make them hate each other,” she said.

She said that Congress always used the social media for the benefit of the country. If the new generation realises this fact, the country will once again turn its direction towards development, she asserted.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.